|
12 Oct 2017 |
Targovax announces one-year survival rate and safety data in the modified cohort of the TG01 trial in resected pancreatic cancer
|
|
03 Oct 2017 |
PnuVax Awarded $29.4 Million USD Grant to Advance Innovative Vaccine into Clinical Trials
|
|
28 Sep 2017 |
Moderna Announces Publication in Molecular Therapy Characterizing Potent Immune Response Generated by Its mRNA Prophylactic Vaccines
|
|
27 Sep 2017 |
Medicago Announces Phase 3 Study of VLP Quadrivalent Influenza Vaccine
|
|
27 Sep 2017 |
Aduro Biotech Announces First Patient Dosed in Phase 1 Clinical Trial of Personalized Immunotherapy pLADD Based on Proprietary Neoantigen Technology
|
|
25 Sep 2017 |
Sinovac Reports Preliminary Top-Line Results from Phase III Clinical Trial for Varicella Vaccine Candidate Against Chickenpox
|
|
21 Sep 2017 |
Bavarian Nordic Provides Update on its Universal RSV Vaccine
|
|
21 Sep 2017 |
Altimmune Announces its Phase 2 Flu Vaccine Trial with NasoVAX Open for Enrollment
|
|
19 Sep 2017 |
Novavax Initiates Phase 1/2 Trial of NanoFlu™ Vaccine in Older Adults
|
|
19 Sep 2017 |
Transgene: First Patient Treated in a Phase 1b/2 Trial of TG4001 in Combination with Avelumab in HPV-Positive Cancers
|
|
18 Sep 2017 |
Inovio and Partners Initiate Phase 1/2a Clinical Trial To Further Advance Its Vaccine Against Deadly MERS Infection
|
|
15 Sep 2017 |
Independent Data Monitoring Committee Recommends Discontinuation of Bavarian Nordic’s Phase 3 Study of PROSTVAC in Metastatic Prostate Cancer
|
|
14 Sep 2017 |
SELLAS' Galinpepimut-S Induces Specific, Robust and Durable Immune Responses in Patients With High-Risk Multiple Myeloma - Correlated With Clinical Benefit
|
|
14 Sep 2017 |
Successful Phase III trial for ALK’s tree allergy SLIT-tablet
|
|
14 Sep 2017 |
OncBioMune Meets Primary Objective in Trial of ProscaVax Immunotherapy Vaccine for Prostate Cancer
|
|
14 Sep 2017 |
Argos Therapeutics Reports on Interim Analysis of Phase 3 ADAPT Trial Presented at ESMO 2017 Congress
|
|
14 Sep 2017 |
FDA Advisory Committee votes unanimously for Shingrix (HZ/su) in the US for prevention of herpes zoster (shingles) in adults ages 50 and over
|
|
12 Sep 2017 |
AC Immune completes Recruitment for Low-Dose Cohort of Participants in World's First Clinical Trial for anti-Abeta Vaccine Targeting Alzheimer's Disease-like Characteristics in Individuals with Down Syndrome
|
|
11 Sep 2017 |
Inovio’s Cancer Immunotherapy (INO-5150) Slowed PSA Rise and Significantly Increased PSA Doubling Times In Patients with Recurrent Prostate Cancer
|
|
08 Sep 2017 |
New Randomized Data From CMB305 + Checkpoint Inhibitor Study Demonstrate Greater Clinical Benefit and Immune Response
|
|
07 Sep 2017 |
Anergis Announces Top Line Results from Large-Scale ATIBAR Trial with Ultra-Fast Allergy Immunotherapy AllerT
|
|
06 Sep 2017 |
Argos Announces First Dosing of HIV Patient with AGS-004 Derived from the Latent Viral Reservoir
|
|
06 Sep 2017 |
AbbVie Submits New Drug Application to U.S. FDA for Investigational Oral Treatment Elagolix for the Management of Endometriosis with Associated Pain
|
|
06 Sep 2017 |
Aelix Therapeutics Enrolls First Patient In Company’s Initial Therapeutic HIV Vaccine Clinical Trial
|
|
05 Sep 2017 |
VAXIMM Announces Preclinical Results with Novel Oral T-cell Cancer Immunotherapies Being Presented at Third CRI-CIMT-EATI-AACR Conference
|
